302 related articles for article (PubMed ID: 32375196)
1. Role of Factor XIa and Plasma Kallikrein in Arterial and Venous Thrombosis.
Visser M; Heitmeier S; Ten Cate H; Spronk HMH
Thromb Haemost; 2020 Jun; 120(6):883-993. PubMed ID: 32375196
[TBL] [Abstract][Full Text] [Related]
2. Plasma Kallikrein Contributes to Coagulation in the Absence of Factor XI by Activating Factor IX.
Visser M; van Oerle R; Ten Cate H; Laux V; Mackman N; Heitmeier S; Spronk HMH
Arterioscler Thromb Vasc Biol; 2020 Jan; 40(1):103-111. PubMed ID: 31766871
[TBL] [Abstract][Full Text] [Related]
3. Factor XII promotes blood coagulation independent of factor XI in the presence of long-chain polyphosphates.
Puy C; Tucker EI; Wong ZC; Gailani D; Smith SA; Choi SH; Morrissey JH; Gruber A; McCarty OJ
J Thromb Haemost; 2013 Jul; 11(7):1341-52. PubMed ID: 23659638
[TBL] [Abstract][Full Text] [Related]
4. A comparison of the effects of factor XII deficiency and prekallikrein deficiency on thrombus formation.
Kokoye Y; Ivanov I; Cheng Q; Matafonov A; Dickeson SK; Mason S; Sexton DJ; Renné T; McCrae K; Feener EP; Gailani D
Thromb Res; 2016 Apr; 140():118-124. PubMed ID: 26950760
[TBL] [Abstract][Full Text] [Related]
5. Evidence for factor IX-independent roles for factor XIa in blood coagulation.
Matafonov A; Cheng Q; Geng Y; Verhamme IM; Umunakwe O; Tucker EI; Sun MF; Serebrov V; Gruber A; Gailani D
J Thromb Haemost; 2013 Dec; 11(12):2118-27. PubMed ID: 24152424
[TBL] [Abstract][Full Text] [Related]
6. The contact activation and kallikrein/kinin systems: pathophysiologic and physiologic activities.
Schmaier AH
J Thromb Haemost; 2016 Jan; 14(1):28-39. PubMed ID: 26565070
[TBL] [Abstract][Full Text] [Related]
7. Nucleic acids as cofactors for factor XI and prekallikrein activation: Different roles for high-molecular-weight kininogen.
Ivanov I; Shakhawat R; Sun MF; Dickeson SK; Puy C; McCarty OJ; Gruber A; Matafonov A; Gailani D
Thromb Haemost; 2017 Apr; 117(4):671-681. PubMed ID: 28124063
[TBL] [Abstract][Full Text] [Related]
8. The evolution of factor XI and the kallikrein-kinin system.
Ponczek MB; Shamanaev A; LaPlace A; Dickeson SK; Srivastava P; Sun MF; Gruber A; Kastrup C; Emsley J; Gailani D
Blood Adv; 2020 Dec; 4(24):6135-6147. PubMed ID: 33351111
[TBL] [Abstract][Full Text] [Related]
9. A role for factor XIIa-mediated factor XI activation in thrombus formation in vivo.
Cheng Q; Tucker EI; Pine MS; Sisler I; Matafonov A; Sun MF; White-Adams TC; Smith SA; Hanson SR; McCarty OJ; Renné T; Gruber A; Gailani D
Blood; 2010 Nov; 116(19):3981-9. PubMed ID: 20634381
[TBL] [Abstract][Full Text] [Related]
10. Role of platelets in regulating activated coagulation factor XI activity.
Reitsma SE; Pang J; Raghunathan V; Shatzel JJ; Lorentz CU; Tucker EI; Gruber A; Gailani D; McCarty OJT; Puy C
Am J Physiol Cell Physiol; 2021 Mar; 320(3):C365-C374. PubMed ID: 33471623
[TBL] [Abstract][Full Text] [Related]
11. Predictive value for increased activated factor XI activity in acute venous thromboembolism.
Nagy M; Robles AP; Visser M; Koeck T; Ten Cate V; Ten Cate-Hoek AJ; Schwers S; Heitmeier S; Ten Cate H; Wild PS; Spronk HMH
J Thromb Haemost; 2023 Jun; 21(6):1610-1622. PubMed ID: 37003466
[TBL] [Abstract][Full Text] [Related]
12. Effects of plasma kallikrein deficiency on haemostasis and thrombosis in mice: murine ortholog of the Fletcher trait.
Bird JE; Smith PL; Wang X; Schumacher WA; Barbera F; Revelli JP; Seiffert D
Thromb Haemost; 2012 Jun; 107(6):1141-50. PubMed ID: 22398951
[TBL] [Abstract][Full Text] [Related]
13. A renaissance for the contact system in blood coagulation?
Blat Y; Seiffert D
Thromb Haemost; 2008 Mar; 99(3):457-60. PubMed ID: 18327389
[No Abstract] [Full Text] [Related]
14. Analysis of the factor XI variant Arg184Gly suggests a structural basis for factor IX binding to factor XIa.
Geng Y; Verhamme IM; Sun MF; Bajaj SP; Emsley J; Gailani D
J Thromb Haemost; 2013 Jul; 11(7):1374-84. PubMed ID: 23617568
[TBL] [Abstract][Full Text] [Related]
15. Factor XI and contact activation as targets for antithrombotic therapy.
Gailani D; Bane CE; Gruber A
J Thromb Haemost; 2015 Aug; 13(8):1383-95. PubMed ID: 25976012
[TBL] [Abstract][Full Text] [Related]
16. A mechanism for hereditary angioedema with normal C1 inhibitor: an inhibitory regulatory role for the factor XII heavy chain.
Ivanov I; Matafonov A; Sun MF; Mohammed BM; Cheng Q; Dickeson SK; Kundu S; Verhamme IM; Gruber A; McCrae K; Gailani D
Blood; 2019 Mar; 133(10):1152-1163. PubMed ID: 30591525
[TBL] [Abstract][Full Text] [Related]
17. The dimeric structure of factor XI and zymogen activation.
Geng Y; Verhamme IM; Smith SB; Sun MF; Matafonov A; Cheng Q; Smith SA; Morrissey JH; Gailani D
Blood; 2013 May; 121(19):3962-9. PubMed ID: 23515926
[TBL] [Abstract][Full Text] [Related]
18. Factor XII in coagulation, inflammation and beyond.
Didiasova M; Wujak L; Schaefer L; Wygrecka M
Cell Signal; 2018 Nov; 51():257-265. PubMed ID: 30118759
[TBL] [Abstract][Full Text] [Related]
19. High molecular weight kininogen interactions with the homologs prekallikrein and factor XI: importance to surface-induced coagulation.
Mohammed BM; Sun MF; Cheng Q; Litvak M; McCrae KR; Emsley J; McCarty OJT; Gailani D
J Thromb Haemost; 2024 Jan; 22(1):225-237. PubMed ID: 37813198
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of factor XIa as a new approach to anticoagulation.
Schumacher WA; Luettgen JM; Quan ML; Seiffert DA
Arterioscler Thromb Vasc Biol; 2010 Mar; 30(3):388-92. PubMed ID: 20139363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]